The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic

Non-alcoholic Fatty Liver Disease in Children

Risk estimation model for nonalcoholic fatty liver disease in the Japanese using multiple genetic markers

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent - ScienceDirect

Precision medicine in nonalcoholic fatty liver disease: New therapeutic insights from genetics and systems biology

Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity, Egyptian Journal of Medical Human Genetics

Lack of evidence supporting a role of TMC4-rs641738 missense variant—MBOAT7- intergenic downstream variant—in the Susceptibility to Nonalcoholic Fatty Liver Disease

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent - ScienceDirect

The MBOAT7-TMC4 Variant rs641738 Increases Risk of Nonalcoholic Fatty Liver Disease in Individuals of European Descent - ScienceDirect

Genetic risk of fatty liver disease and mortality in the general population: A Mendelian randomization study - Gellert‐Kristensen - 2023 - Liver International - Wiley Online Library

Obesity-linked suppression of membrane-bound O-acyltransferase 7 (MBOAT7) drives non-alcoholic fatty liver disease

Genetic and metabolic aspects of non-alcoholic fatty liver disease (NAFLD) pathogenicity, Egyptian Journal of Medical Human Genetics

PDF] A Protein‐Truncating HSD17B13 Variant and Protection from Chronic Liver Disease

Expression of Membrane Bound O-Acyltransferase Domain Containing 7 after Myocardial Infarction and its Role in Lipid Metabolism in vitro

Evolution of Non-alcoholic Fatty Liver Disease to Liver Cancer: Insights from Genome-wide Association Studies